Chromatography in Biologics Manufacturing: Purification Science, Resin Applications, and System Qualification
Chromatography in Biologics Manufacturing: Science, Purpose, and Resin Applications Chromatography is a critical purification technique used in many evolving fields of biologics manufacturing including monoclonal...
Read MoreFrom Day One Success to Everyday Improvement: The OR → OE Continuum
Written by Paige Kane, PhD, CPIP If you work in Life Sciences, you know that it is a complex, high-stakes operation. I’ve been through my...
Read MoreHuman Performance In Pharma: Strengthening The Biotech Workforce
Elevating human performance in pharma starts with addressing the workforce shortage and continues by transforming how organizations develop and support their people. Through strategic collaboration...
Read MoreReimagining Pharmaceutical Manufacturing: Why the latest E2500-25 Standard Revision Demands Immediate Action
Speed to patient is a primary driver behind the industry's shift toward modern commissioning and qualification (C&Q) practices, while still ensuring product quality and patient...
Read MoreEU GMP Annex 1 Compliance: Global Requirements & PIC/S Alignment
The 2023 revision of EU GMP Annex 1 reset the global standard for sterile manufacturing. It expands the guidance, tightens contamination-control expectations and aligns requirements...
Read MoreWINDSOR FRAMEWORK: WHAT IS IT?
The Windsor Framework (WF), which came into effect on January 1, 2025, is a significant agreement between the UK and the EU that replaces the...
Read MoreCAI Appoints Jamie Robertson as Vice President of Mission Critical to Drive Innovation and Operational Excellence Across Global Infrastructure Projects
August 11, 2025 – Indianapolis, IN — CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the...
Read MoreUnderstanding cGMPs for Phase 1 Investigational Drugs
In 2008, the FDA issued guidance exempting most Phase 1 investigational drugs from the full scope of Title 21 of the Code of Federal Regulations...
Read MoreCAI and Valkit.ai Form Strategic Partnership to Advance Gen2 AI-Augmented Validation (DVT) in Life Sciences
CAI and Valkit.ai Form Strategic Partnership to Advance Gen2 AI-Augmented Validation (DVT) in Life Sciences Indianapolis, IN – September 29, 2025 — CAI, a global...
Read More
